| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > How CEO's Can Use Axiology To Improve The Bottom Line Part I |
|
Digg It - How CEO's Can Use Axiology To Improve The Bottom Line Part I
In today's fast-paced business world, CEO's are trying to keep up with change and adapt to the global marketplace, constantly searching the horizon for an edge over the competition. One thing they overlook is very close to home. In fact it is just down the hall from them. It According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product 's their very own employees. By learning how to unlock the hidden potential of your employees and executives you can create multiple leverage points for your business that your competition cannot duplicate because it's unique to you. Your employee mix is yours and yours alone ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in You owe it to your company to get the best from your employee's; their minds, their strengths and their keen abilities. Imagine if all employees utilized all their strengths and could know and understand the roadblocks that hold them back? Playing at the "top of their game" lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. hey would make better decisions for the company, help reduce expenses and contribute to higher profits. So much can be achieved by simply knowing a person's strengths. It can help build confidence in their ability to make and carry out decisions. It's as critical to know the here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe areas in which they need help. Create an atmosphere where people are not afraid to ask for help or guidance. Employees become more willing to ask for help before a situation becomes critical if they accept, that like others, they are not perfect and nobody really "knows it al d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ". This fear of asking for help holds people back and stunts the growth of companies. When nothing holds a person back, he/she can surge forward with the power and confidence of someone on a mission. So the question to ask is, "How do we structure a program for our people t ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc discover their true strengths and their roadblocks to achievement?" The answer is a little known science called Axiology, the study of values and judgments. The Value Profile is the tool of Axiology that unlocks a person's hidden value. It reveals how you can make better dec easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi isions based on how you think and what you value. Here is a scenario to give you an idea on how Axiology and the Value Profile help CEO's obtain greater leverage from an employee's strength. The CEO, lets call him Richard, has to make a tough decision. He needs to expand his nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically company in order to keep ahead of the competition. Richard decides to put someone in charge of a Special Projects team to determine where the company's best opportunities for the future are. Using the Value Profile, Richard can accurately measure and compare possible candidat and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ s for the position. There are 120 different critical areas with pinpoint and objective information that can be obtained from each individual. The first section of the report determines a person's skill in Deciding What Needs to Be Done. This report measures a candidate's abil ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ty to decide what issues are relevant and what issues require attention. The findings would provide insight on the candidate's ability to rely on analytical as well as "gut" instincts, both critical allies to executives making important decisions. The profile also provides la ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ser accuracy into how well a candidate "sees the big picture" and how the pieces of the picture fit together to make a whole. Added insights include measuring ability to use practical thinking and the ability to project a goal into the future and develop a plan to attain it. dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod In the second section of the report, Developing a Strategy, Richard gains insights on the candidate's ability to plan and manage the project. This is the only tool that provides you with specifics of how each candidate can plan for consequences of actions and decisions, and ho cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin he reacts to crises. As a CEO, it's more important than ever for you to know which candidate best knows how to quickly identify the source of a problem and the factors relating to the problem. You can know which candidate has the best combination of skills to manage the proj tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ect and move your company forward if you know who has the ability to come up with alternative solutions for problems and who can control the flow of events. But it doesn't stop there. You can take an even closer look at your selection of candidates. In the third section of th t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel report you take out your magnifying glass and see the management abilities of the candidates. Utilizing this section of the report, Richard can benchmark each candidate's ability to identify problems and critical issues. You know how well they can determine what needs to be ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust one and whether or not they know how to do it in the most effective manner. Another component of the report tells you if they can determine and understand what is needed to carry out your objectives, whether they are clear about potential problems and the abilities of their p y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products eople to resolve those situations. The last part of this section provides Richard with a clear picture of which candidates are best equipped to create an efficient process or manage a system that others can follow. These are a few of the many insights Axiology and the Value . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de rofile can provide Richard and other CEO's who want to fulfill the vision they have for the future of their company. There's more to come; this is the first part of a three part article series. In the second article Richard, our CEO, will discover how he can assess the candid elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tes' organizational abilities, inner drive to succeed, and how much of a self-starter each candidate is. (c) 2004, Team Results Inc. and Axelrod & Associates, All rights in all media reserved. Reprint rights granted so long as the article and the by-lines are reprinted intact tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:News Flash!! Bad Speling Afekts Biznez! Weeding Out The Old, Making Way For The New
|